These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3034037)

  • 1. Influence of renal function on the pharmacokinetics of ramipril (HOE 498).
    Debusmann ER; Pujadas JO; Lahn W; Irmisch R; Jané F; Kuan TS; Mora J; Walter U; Eckert HG; Hajdú P
    Am J Cardiol; 1987 Apr; 59(10):70D-78D. PubMed ID: 3034037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ramipril in the elderly.
    Meyer BH; Müller FO; Badian M; Eckert HG; Hajdú P; Irmisch R; Schmidt D
    Am J Cardiol; 1987 Apr; 59(10):33D-37D. PubMed ID: 3034031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of ramipril in renal failure.
    Aurell M; Delin K; Herlitz H; Ljungman S; Witte PU; Irmisch R
    Am J Cardiol; 1987 Apr; 59(10):65D-69D. PubMed ID: 3034036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.
    Witte PU; Irmisch R; Hajdú P; Metzger H
    Eur J Clin Pharmacol; 1984; 27(5):577-81. PubMed ID: 6097458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency.
    Schunkert H; Kindler J; Gassmann M; Lahn W; Irmisch R; Ritz E; Debusmann ER; Pujadas JO; Koch KM; Sieberth HG
    Eur J Clin Pharmacol; 1989; 37(3):249-56. PubMed ID: 2533075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state kinetics of ramipril in renal failure.
    Schunkert H; Kindler J; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Sieberth HG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S52-4. PubMed ID: 2474104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
    Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients.
    Gilchrist WJ; Beard K; Manhem P; Thomas EM; Robertson JI; Ball SG
    Am J Cardiol; 1987 Apr; 59(10):28D-32D. PubMed ID: 3034029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
    Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
    Luck C; Verho M; Umscheid T; Stelter WJ; Ziegler HP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S116-21. PubMed ID: 1725018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a single dose of ramipril in patients with renal dysfunction: comparison with essential hypertension.
    Shionoiri H; Miyakawa T; Yasuda G; Ishikawa Y; Umemura S; Miyajima E; Kaneko Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S145-7. PubMed ID: 2485051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
    Bussien JP; Nussberger J; Porchet M; Waeber B; Brunner HR; Perisic M; Tansey MJ; Bomm M; Hajdu P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
    Desmoulins PO; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of ramipril.
    Ball SG; Robertson JI
    Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man.
    Verho M; Luck C; Stelter WJ; Rangoonwala B; Bender N
    Curr Med Res Opin; 1995; 13(5):264-73. PubMed ID: 7555035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
    Levitt DG; Schoemaker RC
    BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
    Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
    Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Serrano Caballero JM; Muñoz A
    Vet J; 2016 Feb; 208():38-43. PubMed ID: 26639833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacology of ramipril.
    Omosu M; Komine I; Becker RH; Schölkens BA
    Arzneimittelforschung; 1988 Sep; 38(9):1309-17. PubMed ID: 2975947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.